In comparison with patients with F3, patients withcirrhosis were more frequently white and enrolled inthe United States, had more diabetes, lower alanineaminotransferase, albumin, hemoglobin, and plateletcount (P < .01) (Tables 1 and 2). In addition, patientswith cirrhosis had higher bilirubin, alkaline phosphatase, fasting HOMA score, bile acid, alpha-2-macroglobulin, C-reactive protein, gamma-glutamyltransferase levels, and international normalized ratio(P < .01). Furthermore, those patients had substantially higher scores related to severity of their liver disease,such as MELD score, noninvasive fibrosis scores (APRI,ELF, FIB-4), as well as greater liver stiffness by transientelastography (TE) and higher collagen percent area (allP < .0001) (Table 2).